Research ArticleRESEARCH

Establishment of Critical Contamination Risk Locations (“Hot Spots”) in Environmental Monitoring by Means of Three-Dimensional Airflow Analysis and Particulate Evaluation

Hirohito Katayama, Takashi Higo, Yuji Tokunaga, Yukio Hiyama and Kaoru Morikawa
PDA Journal of Pharmaceutical Science and Technology January 2005, 59 (1) 49-63;

Article Information

vol. 59 no. 1 49-63
PubMed 
15796135
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online January 1, 2005.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Hirohito Katayama1,
  2. Takashi Higo*,
  3. Yuji Tokunaga1,
  4. Yukio Hiyama2 and
  5. Kaoru Morikawa2
  1. 1Fujisawa Pharmaceutical Co., Ltd, Pharmaceutical Science Laboratories, Osaka, Japan
  2. 2National Institute of Health Sciences, Japan
  1. *Author to whom correspondence should be addressed:
    Fujisawa Pharmaceutical Co., Ltd, Pharmaceutical Science Laboratories, 1-6, Kashima 2-chome, Yodogawa-ku, Osaka 532-8514, Japan.
    Phone: 81-6-6390-1178. Fax: 81-6-6304-1399. E-mail: hirohito_katayama{at}po.fujisawa.co.jp

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
Establishment of Critical Contamination Risk Locations (“Hot Spots”) in Environmental Monitoring by Means of Three-Dimensional Airflow Analysis and Particulate Evaluation
Hirohito Katayama, Takashi Higo, Yuji Tokunaga, Yukio Hiyama, Kaoru Morikawa
PDA Journal of Pharmaceutical Science and Technology Jan 2005, 59 (1) 49-63;
Twitter logo Facebook logo Mendeley logo

Jump to section